Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 102 entries
Sorted by: Best Match Show Resources per page
A Ruptured Mitral Valve Aneurysm as Complication of a Bicuspid Aortic Valve Endocarditis.

Journal of cardiovascular echography

Muscente F, Scarano M, Clemente D, Pezzuoli F, Parato VM.
PMID: 28465987
J Cardiovasc Echogr. 2017 Jan-Mar;27(1):23-25. doi: 10.4103/2211-4122.199063.

We present a case of a ruptured mitral valve (MV) aneurysm as a complication of a bicuspid aortic valve (BAV) endocarditis. It is about a young 35-year-old man, admitted to Cardiology Unit because of unexpected heart failure picture. We...

Cite
Muscente F, Scarano M, Clemente D, et al. A Ruptured Mitral Valve Aneurysm as Complication of a Bicuspid Aortic Valve Endocarditis. J Cardiovasc Echogr. 2017;27(1):23-25doi: 10.4103/2211-4122.199063.
Muscente, F., Scarano, M., Clemente, D., Pezzuoli, F., & Parato, V. M. (2017). A Ruptured Mitral Valve Aneurysm as Complication of a Bicuspid Aortic Valve Endocarditis. Journal of cardiovascular echography, 27(1), 23-25. https://doi.org/10.4103/2211-4122.199063
Muscente, Francesca, et al. "A Ruptured Mitral Valve Aneurysm as Complication of a Bicuspid Aortic Valve Endocarditis." Journal of cardiovascular echography vol. 27,1 (2017): 23-25. doi: https://doi.org/10.4103/2211-4122.199063
Muscente F, Scarano M, Clemente D, Pezzuoli F, Parato VM. A Ruptured Mitral Valve Aneurysm as Complication of a Bicuspid Aortic Valve Endocarditis. J Cardiovasc Echogr. 2017 Jan-Mar;27(1):23-25. doi: 10.4103/2211-4122.199063. PMID: 28465987; PMCID: PMC5353471.
Copy Download .nbib Format: NLM
Thyroid and heart, a clinically relevant relationship.

Journal of endocrinological investigation

Corona G, Croce L, Sparano C, Petrone L, Sforza A, Maggi M, Chiovato L, Rotondi M.
PMID: 34033065
J Endocrinol Invest. 2021 Dec;44(12):2535-2544. doi: 10.1007/s40618-021-01590-9. Epub 2021 May 25.

BACKGROUND: Thyroid disorders, both overt and subclinical, are highly prevalent conditions in the general population. Although a clear relationship between overt thyroid dysfunctions and cardiovascular complications has long been established, data regarding subclinical thyroid dysfunction are by far more...

Cite
Corona G, Croce L, Sparano C, et al. Thyroid and heart, a clinically relevant relationship. J Endocrinol Invest. 2021;44(12):2535-2544doi: 10.1007/s40618-021-01590-9.
Corona, G., Croce, L., Sparano, C., Petrone, L., Sforza, A., Maggi, M., Chiovato, L., & Rotondi, M. (2021). Thyroid and heart, a clinically relevant relationship. Journal of endocrinological investigation, 44(12), 2535-2544. https://doi.org/10.1007/s40618-021-01590-9
Corona, G, et al. "Thyroid and heart, a clinically relevant relationship." Journal of endocrinological investigation vol. 44,12 (2021): 2535-2544. doi: https://doi.org/10.1007/s40618-021-01590-9
Corona G, Croce L, Sparano C, Petrone L, Sforza A, Maggi M, Chiovato L, Rotondi M. Thyroid and heart, a clinically relevant relationship. J Endocrinol Invest. 2021 Dec;44(12):2535-2544. doi: 10.1007/s40618-021-01590-9. Epub 2021 May 25. PMID: 34033065; PMCID: PMC8572180.
Copy Download .nbib Format: NLM
Investigating Trends in the Quality of Reporting of Patient-Reported Outcomes in Oncology Over Time: Analysis of 631 Randomized Controlled Trials Published Between 2004 and 2019.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Efficace F, Giesinger JM, Cella D, Cottone F, Sparano F, Vignetti M, Aaronson NK.
PMID: 34838268
Value Health. 2021 Dec;24(12):1715-1719. doi: 10.1016/j.jval.2021.06.003. Epub 2021 Aug 09.

OBJECTIVES: Incomplete reporting of key information on patient-reported outcomes (PROs) in randomized controlled trials (RCTs) in oncology has been highlighted repeatedly as a major barrier to the use of study findings in clinical practice. We investigated whether the quality...

Cite
Efficace F, Giesinger JM, Cella D, et al. Investigating Trends in the Quality of Reporting of Patient-Reported Outcomes in Oncology Over Time: Analysis of 631 Randomized Controlled Trials Published Between 2004 and 2019. Value Health. 2021;24(12):1715-1719doi: 10.1016/j.jval.2021.06.003.
Efficace, F., Giesinger, J. M., Cella, D., Cottone, F., Sparano, F., Vignetti, M., & Aaronson, N. K. (2021). Investigating Trends in the Quality of Reporting of Patient-Reported Outcomes in Oncology Over Time: Analysis of 631 Randomized Controlled Trials Published Between 2004 and 2019. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 24(12), 1715-1719. https://doi.org/10.1016/j.jval.2021.06.003
Efficace, Fabio, et al. "Investigating Trends in the Quality of Reporting of Patient-Reported Outcomes in Oncology Over Time: Analysis of 631 Randomized Controlled Trials Published Between 2004 and 2019." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 24,12 (2021): 1715-1719. doi: https://doi.org/10.1016/j.jval.2021.06.003
Efficace F, Giesinger JM, Cella D, Cottone F, Sparano F, Vignetti M, Aaronson NK. Investigating Trends in the Quality of Reporting of Patient-Reported Outcomes in Oncology Over Time: Analysis of 631 Randomized Controlled Trials Published Between 2004 and 2019. Value Health. 2021 Dec;24(12):1715-1719. doi: 10.1016/j.jval.2021.06.003. Epub 2021 Aug 09. PMID: 34838268.
Copy Download .nbib Format: NLM
Lifestyle and Mediterranean diet adherence in a cohort of Southern Italian patients with Multiple Sclerosis.

Multiple sclerosis and related disorders

Esposito S, Sparaco M, Maniscalco GT, Signoriello E, Lanzillo R, Russo C, Carmisciano L, Cepparulo S, Lavorgna L, Gallo A, Trojsi F, Brescia Morra V, Lus G, Tedeschi G, Saccà F, Signori A, Bonavita S.
PMID: 33333418
Mult Scler Relat Disord. 2021 Jan;47:102636. doi: 10.1016/j.msard.2020.102636. Epub 2020 Nov 22.

BACKGROUND/OBJECTIVES: Several studies supported the beneficial effects of the Mediterranean diet (MeDi) on chronic diseases. In Multiple Sclerosis (MS), the MeDi might interfere with systemic inflammatory state, gut microbiota, and comorbidities. The Med Diet Score (MDS) estimates the adherence...

Cite
Esposito S, Sparaco M, Maniscalco GT, et al. Lifestyle and Mediterranean diet adherence in a cohort of Southern Italian patients with Multiple Sclerosis. Mult Scler Relat Disord. 2020;47:102636doi: 10.1016/j.msard.2020.102636.
Esposito, S., Sparaco, M., Maniscalco, G. T., Signoriello, E., Lanzillo, R., Russo, C., Carmisciano, L., Cepparulo, S., Lavorgna, L., Gallo, A., Trojsi, F., Brescia Morra, V., Lus, G., Tedeschi, G., Saccà, F., Signori, A., & Bonavita, S. (2021). Lifestyle and Mediterranean diet adherence in a cohort of Southern Italian patients with Multiple Sclerosis. Multiple sclerosis and related disorders, 47102636. https://doi.org/10.1016/j.msard.2020.102636
Esposito, S, et al. "Lifestyle and Mediterranean diet adherence in a cohort of Southern Italian patients with Multiple Sclerosis." Multiple sclerosis and related disorders vol. 47 (2021): 102636. doi: https://doi.org/10.1016/j.msard.2020.102636
Esposito S, Sparaco M, Maniscalco GT, Signoriello E, Lanzillo R, Russo C, Carmisciano L, Cepparulo S, Lavorgna L, Gallo A, Trojsi F, Brescia Morra V, Lus G, Tedeschi G, Saccà F, Signori A, Bonavita S. Lifestyle and Mediterranean diet adherence in a cohort of Southern Italian patients with Multiple Sclerosis. Mult Scler Relat Disord. 2021 Jan;47:102636. doi: 10.1016/j.msard.2020.102636. Epub 2020 Nov 22. PMID: 33333418.
Copy Download .nbib Format: NLM
A Dermatological Questionnaire for General Practitioners with a Focus on Hidradenitis Suppurativa.

Open access Macedonian journal of medical sciences

Marasca C, Annunziata MC, Cacciapuoti S, Cantelli M, Martora F, Scotti S, Sparano L, Fabbrocini G.
PMID: 30455771
Open Access Maced J Med Sci. 2018 Oct 03;6(10):1902-1905. doi: 10.3889/oamjms.2018.358. eCollection 2018 Oct 25.

BACKGROUND: Hidradenitis suppurativa (HS) is a skin chronic inflammatory disease typically located in several areas such as perianal, inguinal and axillary regions. In 40% to 70% of cases, general practitioners (GPs) are the first health care professionals consulted by...

Cite
Marasca C, Annunziata MC, Cacciapuoti S, et al. A Dermatological Questionnaire for General Practitioners with a Focus on Hidradenitis Suppurativa. Open Access Maced J Med Sci. 2018;6(10):1902-1905doi: 10.3889/oamjms.2018.358.
Marasca, C., Annunziata, M. C., Cacciapuoti, S., Cantelli, M., Martora, F., Scotti, S., Sparano, L., & Fabbrocini, G. (2018). A Dermatological Questionnaire for General Practitioners with a Focus on Hidradenitis Suppurativa. Open access Macedonian journal of medical sciences, 6(10), 1902-1905. https://doi.org/10.3889/oamjms.2018.358
Marasca, Claudio, et al. "A Dermatological Questionnaire for General Practitioners with a Focus on Hidradenitis Suppurativa." Open access Macedonian journal of medical sciences vol. 6,10 (2018): 1902-1905. doi: https://doi.org/10.3889/oamjms.2018.358
Marasca C, Annunziata MC, Cacciapuoti S, Cantelli M, Martora F, Scotti S, Sparano L, Fabbrocini G. A Dermatological Questionnaire for General Practitioners with a Focus on Hidradenitis Suppurativa. Open Access Maced J Med Sci. 2018 Oct 03;6(10):1902-1905. doi: 10.3889/oamjms.2018.358. eCollection 2018 Oct 25. PMID: 30455771; PMCID: PMC6236034.
Copy Download .nbib Format: NLM
Minimal Extrathyroidal Extension in Predicting 1-Year Outcomes: A Longitudinal Multicenter Study of Low-to-Intermediate-Risk Papillary Thyroid Carcinoma (ITCO#4).

Thyroid : official journal of the American Thyroid Association

Forleo R, Grani G, Alfò M, Zilioli V, Giubbini R, Zatelli MC, Gagliardi I, Piovesan A, Ragni A, Morelli S, Puxeddu E, Pagano L, Deandrea M, Ceresini G, Torlontano M, Puligheddu B, Antonelli A, Centanni M, Fugazzola L, Spiazzi G, Monti S, Rossetto R, Monzani F, Tallini G, Crescenzi A, Sparano C, Bruno R, Repaci A, Tumino D, Pezzullo L, Lombardi CP, Ferraro Petrillo U, Filetti S, Durante C, Castagna MG.
PMID: 34541894
Thyroid. 2021 Dec;31(12):1814-1821. doi: 10.1089/thy.2021.0248. Epub 2021 Oct 20.

No abstract available.

Cite
Forleo R, Grani G, Alfò M, et al. Minimal Extrathyroidal Extension in Predicting 1-Year Outcomes: A Longitudinal Multicenter Study of Low-to-Intermediate-Risk Papillary Thyroid Carcinoma (ITCO#4). Thyroid. 2021;31(12):1814-1821doi: 10.1089/thy.2021.0248.
Forleo, R., Grani, G., Alfò, M., Zilioli, V., Giubbini, R., Zatelli, M. C., Gagliardi, I., Piovesan, A., Ragni, A., Morelli, S., Puxeddu, E., Pagano, L., Deandrea, M., Ceresini, G., Torlontano, M., Puligheddu, B., Antonelli, A., Centanni, M., Fugazzola, L., Spiazzi, G., Monti, S., Rossetto, R., Monzani, F., Tallini, G., Crescenzi, A., Sparano, C., Bruno, R., Repaci, A., Tumino, D., Pezzullo, L., Lombardi, C. P., Ferraro Petrillo, U., Filetti, S., Durante, C., & Castagna, M. G. (2021). Minimal Extrathyroidal Extension in Predicting 1-Year Outcomes: A Longitudinal Multicenter Study of Low-to-Intermediate-Risk Papillary Thyroid Carcinoma (ITCO#4). Thyroid : official journal of the American Thyroid Association, 31(12), 1814-1821. https://doi.org/10.1089/thy.2021.0248
Forleo, Raffaella, et al. "Minimal Extrathyroidal Extension in Predicting 1-Year Outcomes: A Longitudinal Multicenter Study of Low-to-Intermediate-Risk Papillary Thyroid Carcinoma (ITCO#4)." Thyroid : official journal of the American Thyroid Association vol. 31,12 (2021): 1814-1821. doi: https://doi.org/10.1089/thy.2021.0248
Forleo R, Grani G, Alfò M, Zilioli V, Giubbini R, Zatelli MC, Gagliardi I, Piovesan A, Ragni A, Morelli S, Puxeddu E, Pagano L, Deandrea M, Ceresini G, Torlontano M, Puligheddu B, Antonelli A, Centanni M, Fugazzola L, Spiazzi G, Monti S, Rossetto R, Monzani F, Tallini G, Crescenzi A, Sparano C, Bruno R, Repaci A, Tumino D, Pezzullo L, Lombardi CP, Ferraro Petrillo U, Filetti S, Durante C, Castagna MG. Minimal Extrathyroidal Extension in Predicting 1-Year Outcomes: A Longitudinal Multicenter Study of Low-to-Intermediate-Risk Papillary Thyroid Carcinoma (ITCO#4). Thyroid. 2021 Dec;31(12):1814-1821. doi: 10.1089/thy.2021.0248. Epub 2021 Oct 20. PMID: 34541894.
Copy Download .nbib Format: NLM
Cortical Hyper-Connectivity in a Stroke Patient with Rotated Drawing.

Case reports in neurology

Sebastiani V, Chiacchiaretta P, Pavone L, Sparano A, Grillea G, Spadone S, Capotosto P, Committeri G, Baldassarre A.
PMID: 34899252
Case Rep Neurol. 2021 Oct 19;13(3):677-686. doi: 10.1159/000518844. eCollection 2021.

In the present case report, we investigated the cortical networks of a patient (DDA) affected by right parietal stroke who showed a constructional phenomenon, in which when coping and recalling from memory a complex figure, the model was reproduced...

Cite
Sebastiani V, Chiacchiaretta P, Pavone L, et al. Cortical Hyper-Connectivity in a Stroke Patient with Rotated Drawing. Case Rep Neurol. 2021;13(3):677-686doi: 10.1159/000518844.
Sebastiani, V., Chiacchiaretta, P., Pavone, L., Sparano, A., Grillea, G., Spadone, S., Capotosto, P., Committeri, G., & Baldassarre, A. (2021). Cortical Hyper-Connectivity in a Stroke Patient with Rotated Drawing. Case reports in neurology, 13(3), 677-686. https://doi.org/10.1159/000518844
Sebastiani, Valentina, et al. "Cortical Hyper-Connectivity in a Stroke Patient with Rotated Drawing." Case reports in neurology vol. 13,3 (2021): 677-686. doi: https://doi.org/10.1159/000518844
Sebastiani V, Chiacchiaretta P, Pavone L, Sparano A, Grillea G, Spadone S, Capotosto P, Committeri G, Baldassarre A. Cortical Hyper-Connectivity in a Stroke Patient with Rotated Drawing. Case Rep Neurol. 2021 Oct 19;13(3):677-686. doi: 10.1159/000518844. eCollection 2021. PMID: 34899252; PMCID: PMC8613562.
Copy Download .nbib Format: NLM
Pneumoretroperitoneum Associated with "Dirty Mass": An Unusual Case of Rectal Perforation.

Radiology case reports

Liguori P, Reginelli A, Sparano A, Ruggiero G, Pinto A.
PMID: 27303455
Radiol Case Rep. 2016 Jan 05;2(1):22-3. doi: 10.2484/rcr.v2i1.51. eCollection 2007.

Perforation of the rectum requires early recognition and treatment. The diagnosis of rectal perforation is sometimes difficult owing to non specific clinical presentation, especially in elderly patients, in whom, in case of acute abdomen, Computed Tomography (CT) is increasing...

Cite
Liguori P, Reginelli A, Sparano A, et al. Pneumoretroperitoneum Associated with "Dirty Mass": An Unusual Case of Rectal Perforation. Radiol Case Rep. 2016;2(1):22-3doi: 10.2484/rcr.v2i1.51.
Liguori, P., Reginelli, A., Sparano, A., Ruggiero, G., & Pinto, A. (2007). Pneumoretroperitoneum Associated with "Dirty Mass": An Unusual Case of Rectal Perforation. Radiology case reports, 2(1), 22-3. https://doi.org/10.2484/rcr.v2i1.51
Liguori, Pasquale, et al. "Pneumoretroperitoneum Associated with "Dirty Mass": An Unusual Case of Rectal Perforation." Radiology case reports vol. 2,1 (2007): 22-3. doi: https://doi.org/10.2484/rcr.v2i1.51
Liguori P, Reginelli A, Sparano A, Ruggiero G, Pinto A. Pneumoretroperitoneum Associated with "Dirty Mass": An Unusual Case of Rectal Perforation. Radiol Case Rep. 2016 Jan 05;2(1):22-3. doi: 10.2484/rcr.v2i1.51. eCollection 2007. PMID: 27303455; PMCID: PMC4891616.
Copy Download .nbib Format: NLM
Limited efficacy of lenvatinib in heavily pretreated anaplastic thyroid cancer: a French overview.

Endocrine-related cancer

Sparano C, Godbert Y, Attard M, Do Cao C, Zerdoud S, Roudaut N, Joly C, Berdelou A, Hadoux J, Lamartina L, Schlumberger M, Leboulleux S.
PMID: 33112817
Endocr Relat Cancer. 2021 Jan;28(1):15-26. doi: 10.1530/ERC-20-0106.

Anaplastic thyroid cancer (ATC) is a rare lethal disease. Lenvatinib is an off-label therapeutic option for ATC in most countries, except in Japan. The aim of this multicenter retrospective survey was to analyze the efficacy and the toxicity profile...

Cite
Sparano C, Godbert Y, Attard M, et al. Limited efficacy of lenvatinib in heavily pretreated anaplastic thyroid cancer: a French overview. Endocr Relat Cancer. 2021;28(1):15-26doi: 10.1530/ERC-20-0106.
Sparano, C., Godbert, Y., Attard, M., Do Cao, C., Zerdoud, S., Roudaut, N., Joly, C., Berdelou, A., Hadoux, J., Lamartina, L., Schlumberger, M., & Leboulleux, S. (2021). Limited efficacy of lenvatinib in heavily pretreated anaplastic thyroid cancer: a French overview. Endocrine-related cancer, 28(1), 15-26. https://doi.org/10.1530/ERC-20-0106
Sparano, Clotilde, et al. "Limited efficacy of lenvatinib in heavily pretreated anaplastic thyroid cancer: a French overview." Endocrine-related cancer vol. 28,1 (2021): 15-26. doi: https://doi.org/10.1530/ERC-20-0106
Sparano C, Godbert Y, Attard M, Do Cao C, Zerdoud S, Roudaut N, Joly C, Berdelou A, Hadoux J, Lamartina L, Schlumberger M, Leboulleux S. Limited efficacy of lenvatinib in heavily pretreated anaplastic thyroid cancer: a French overview. Endocr Relat Cancer. 2021 Jan;28(1):15-26. doi: 10.1530/ERC-20-0106. PMID: 33112817.
Copy Download .nbib Format: NLM
Assessment of Multiple Sclerosis Disability Progression Using a Wearable Biosensor: A Pilot Study.

Journal of clinical medicine

Abbadessa G, Lavorgna L, Miele G, Mignone A, Signoriello E, Lus G, Clerico M, Sparaco M, Bonavita S.
PMID: 33802029
J Clin Med. 2021 Mar 10;10(6). doi: 10.3390/jcm10061160.

BACKGROUND: The evaluation of walking activity of people with multiple sclerosis (pwMS) is desirable. We evaluate the power of the correlation of motor parameters detected by the accelerometer in the Samsung Gear S2 smartwatch with multiple sclerosis (MS) disability...

Cite
Abbadessa G, Lavorgna L, Miele G, et al. Assessment of Multiple Sclerosis Disability Progression Using a Wearable Biosensor: A Pilot Study. J Clin Med. 2021;10(6)doi: 10.3390/jcm10061160.
Abbadessa, G., Lavorgna, L., Miele, G., Mignone, A., Signoriello, E., Lus, G., Clerico, M., Sparaco, M., & Bonavita, S. (2021). Assessment of Multiple Sclerosis Disability Progression Using a Wearable Biosensor: A Pilot Study. Journal of clinical medicine, 10(6), . https://doi.org/10.3390/jcm10061160
Abbadessa, Gianmarco, et al. "Assessment of Multiple Sclerosis Disability Progression Using a Wearable Biosensor: A Pilot Study." Journal of clinical medicine vol. 10,6 (2021). doi: https://doi.org/10.3390/jcm10061160
Abbadessa G, Lavorgna L, Miele G, Mignone A, Signoriello E, Lus G, Clerico M, Sparaco M, Bonavita S. Assessment of Multiple Sclerosis Disability Progression Using a Wearable Biosensor: A Pilot Study. J Clin Med. 2021 Mar 10;10(6). doi: 10.3390/jcm10061160. PMID: 33802029; PMCID: PMC8001885.
Copy Download .nbib Format: NLM
Can Magnetic Resonance Radiomics Analysis Discriminate Parotid Gland Tumors? A Pilot Study.

Diagnostics (Basel, Switzerland)

Gabelloni M, Faggioni L, Attanasio S, Vani V, Goddi A, Colantonio S, Germanese D, Caudai C, Bruschini L, Scarano M, Seccia V, Neri E.
PMID: 33153140
Diagnostics (Basel). 2020 Nov 03;10(11). doi: 10.3390/diagnostics10110900.

Our purpose is to evaluate the performance of magnetic resonance (MR) radiomics analysis for differentiating between malignant and benign parotid neoplasms and, among the latter, between pleomorphic adenomas and Warthin tumors. We retrospectively evaluated 75 T2-weighted images of parotid...

Cite
Gabelloni M, Faggioni L, Attanasio S, et al. Can Magnetic Resonance Radiomics Analysis Discriminate Parotid Gland Tumors? A Pilot Study. Diagnostics (Basel). 2020;10(11)doi: 10.3390/diagnostics10110900.
Gabelloni, M., Faggioni, L., Attanasio, S., Vani, V., Goddi, A., Colantonio, S., Germanese, D., Caudai, C., Bruschini, L., Scarano, M., Seccia, V., & Neri, E. (2020). Can Magnetic Resonance Radiomics Analysis Discriminate Parotid Gland Tumors? A Pilot Study. Diagnostics (Basel, Switzerland), 10(11), . https://doi.org/10.3390/diagnostics10110900
Gabelloni, Michela, et al. "Can Magnetic Resonance Radiomics Analysis Discriminate Parotid Gland Tumors? A Pilot Study." Diagnostics (Basel, Switzerland) vol. 10,11 (2020). doi: https://doi.org/10.3390/diagnostics10110900
Gabelloni M, Faggioni L, Attanasio S, Vani V, Goddi A, Colantonio S, Germanese D, Caudai C, Bruschini L, Scarano M, Seccia V, Neri E. Can Magnetic Resonance Radiomics Analysis Discriminate Parotid Gland Tumors? A Pilot Study. Diagnostics (Basel). 2020 Nov 03;10(11). doi: 10.3390/diagnostics10110900. PMID: 33153140; PMCID: PMC7692594.
Copy Download .nbib Format: NLM
Ex vivo lung cancer spheroids resemble treatment response of a patient with NSCLC to chemotherapy and immunotherapy: case report and translational study.

ESMO open

Di Liello R, Ciaramella V, Barra G, Venditti M, Della Corte CM, Papaccio F, Sparano F, Viscardi G, Iacovino ML, Minucci S, Fasano M, Ciardiello F, Morgillo F.
PMID: 31555484
ESMO Open. 2019 Aug 19;4(4):e000536. doi: 10.1136/esmoopen-2019-000536. eCollection 2019.

INTRODUCTION: In the era of precision medicine, research studies are aiming to design patient-tailored treatment strategies. In this work, we present a clinical case of a patient with non-small cell lung cancer (NSCLC) accompanied by a translational study with...

Cite
Di Liello R, Ciaramella V, Barra G, et al. Ex vivo lung cancer spheroids resemble treatment response of a patient with NSCLC to chemotherapy and immunotherapy: case report and translational study. ESMO Open. 2019;4(4):e000536doi: 10.1136/esmoopen-2019-000536.
Di Liello, R., Ciaramella, V., Barra, G., Venditti, M., Della Corte, C. M., Papaccio, F., Sparano, F., Viscardi, G., Iacovino, M. L., Minucci, S., Fasano, M., Ciardiello, F., & Morgillo, F. (2019). Ex vivo lung cancer spheroids resemble treatment response of a patient with NSCLC to chemotherapy and immunotherapy: case report and translational study. ESMO open, 4(4), e000536. https://doi.org/10.1136/esmoopen-2019-000536
Di Liello, Raimondo, et al. "Ex vivo lung cancer spheroids resemble treatment response of a patient with NSCLC to chemotherapy and immunotherapy: case report and translational study." ESMO open vol. 4,4 (2019): e000536. doi: https://doi.org/10.1136/esmoopen-2019-000536
Di Liello R, Ciaramella V, Barra G, Venditti M, Della Corte CM, Papaccio F, Sparano F, Viscardi G, Iacovino ML, Minucci S, Fasano M, Ciardiello F, Morgillo F. Ex vivo lung cancer spheroids resemble treatment response of a patient with NSCLC to chemotherapy and immunotherapy: case report and translational study. ESMO Open. 2019 Aug 19;4(4):e000536. doi: 10.1136/esmoopen-2019-000536. eCollection 2019. PMID: 31555484; PMCID: PMC6735672.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 102 entries